PUNE, India, April 4, 2018 /PRNewswire/ —
ReportsnReports.com adds the microfluidics market is projected to reach USD 27.91 billion by 2023 from estimated USD 10.06 billion in 2018, at a CAGR of 22.6%. Quick returns on investment coupled with the fast results and improved portability of the medical equipment embedded with microfluidics technology are the factors expected to drive the market during the forecast period. However, complex and time-consuming regulatory approvals process for the microfluidics technology into existing workflow is one of the factors restraining the growth of this market.
[…]
The key players in the global microfluidics market are Danaher (US), Thermo Fisher (US), PerkinElmer (US), Agilent (US), Bio-Rad (US), Becton, Dickinson and Company (US), Roche (Switzerland), Illumina (US), Fluidigm Microfluidics (US), and QIAGEN (Netherlands). Other key players include Dolomite Microfluidics (UK), GYROS PROTEIN TECHNOLOGIES AB (Sweden), Sphere Fluidics (UK), OPKO Health (US), Waters (US), thinXXS Microtechnology (Germany), Abaxis (US), BioMérieux (France), Abbott (US), Dolomite Microfluidics (UK), Microfluidic ChipShop (Germany), Elveflow (France), Cellix (Ireland), Micronit Microtechnologies (Netherlands), MicroLiquid (Spain), MiniFAB (Australia), uFluidix (Canada), Micralyne (US), and Fluigent (France).
Understanding how cells decode signals from their environment is a central challenge in biology. One…
The detection and analysis of small extracellular vesicles (sEVs), such as exosomes, has attracted significant…
Magnetite nanoparticles (MNPs) have become valuable in areas ranging from environmental remediation and water treatment…
Efficient delivery of RNA therapeutics hinges on the quality and consistency of lipid nanoparticles (LNPs)…
Skin diseases like atopic dermatitis and psoriasis have been linked to gut health, yet the…
Red blood cell (RBC) deformability, the ability of RBCs to squeeze through tiny capillaries, is…